NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.
Curative Options in Sickle Cell Disease Plenary Session
Assistant Professor of Pediatrics Emory University/Aflac Cancer & Blood Disorders Center Atlanta, Georgia, United States
Disclosure(s):
Elizabeth Stenger, MD: No financial relationships to disclose
Learning Objectives:
Recognize the need for long-term outcomes following hematopoietic cell transplantation (HCT) for sickle cell disease (SCD) beyond traditional survival outcomes
Describe the impact of successful HCT on cardiac, pulmonary, and neurologic function in SCD patients, including risk factors for organ dysfunction
Describe the impact of successful HCT on SCD symptoms
